Russ Cohen

Analysis of Morgan Stanley Downgrade on STAAR Surgical Impact of Morgan Stanley’s Underweight Rating on STAAR Surgical

Bull and bear

adventtr

Morgan Stanley has devalued STAAR Surgical (NASDAQ:STAA) to underweight, citing unrealistic growth expectations for the future.

The investment bank raised concerns over subdued growth forecasts in the Chinese market, projecting a lag in U.S. High Single-Digit (HSD) sales by 2026 compared to street expectations, which anticipate a surge to double-digit growth figures. They labeled this anticipated shift as excessively ambitious.

See also  Stock Market News: Navigating Chinese App Bans Market Alert: Navigating Chinese App Ban Ripples